Finance

Lists
EVGN:NASDAQ
Evogene Ltd
0,39 $
+0,96%
(+0,0037) 1D
0,38 $
-2,00% (-0,0078)
After hours
Closed: 13 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVGN...
Open
0,38 $
High
0,40 $
Low
0,37 $
Mkt. cap
6,98 մլն
Avg. vol.
2,57 մլն
Volume
87,65 հզր
52-wk high
1,49 $
52-wk low
0,35 $
EPS
-0,90 $
Beta
1,44
Shares outstanding
18,05 մլն
No. of employees
52
Open
0,38 $
High
0,40 $
Low
0,37 $
Mkt. cap
6,98 մլն
Avg. vol.
2,57 մլն
Volume
87,65 հզր
52-wk high
1,49 $
52-wk low
0,35 $
EPS
-0,90 $
Beta
1,44
Shares outstanding
18,05 մլն
No. of employees
52
News stories
From web sources and news partners
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd
CEOOfer Haviv
Employees52
Founded2002
Headquarters-
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Buy
Maintained
2,15 $
+451%
05/26/2026
Unknown Analyst
Alliance Global Partners
Buy
Maintained
1,75 $
+348,5%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
312,00 հզր
314,00 հզր
334,00 հզր
347,00 հզր
Cost of goods sold
157,00 հզր
2,28 մլն
130,00 հզր
206,00 հզր
Cost of revenue
157,00 հզր
2,28 մլն
130,00 հզր
206,00 հզր
Research and development expenses
1,38 մլն
1,83 մլն
1,84 մլն
1,10 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,50 մլն
1,20 մլն
1,54 մլն
1,15 մլն
Operating expense
2,88 մլն
3,00 մլն
3,38 մլն
2,25 մլն
Total operating expenses
3,04 մլն
5,28 մլն
3,51 մլն
2,45 մլն
Operating income
-2,72 մլն
-4,97 մլն
-3,18 մլն
-2,10 մլն
Other non operating income
-
668,00 հզր
-
-1,70 մլն
EBT including unusual items
-2,73 մլն
-5,34 մլն
-5,91 մլն
-1,26 մլն
EBT excluding unusual items
-2,73 մլն
-5,09 մլն
-5,94 մլն
-1,13 մլն
Income tax expense
1,00 հզր
-
4,00 հզր
-4,00 հզր
Effective tax rate
-0,04%
-
-0,07%
0,32%
Other operating expenses
9,00 հզր
-27,00 հզր
-
-
Net income
3,87 մլն
-5,31 մլն
-5,87 մլն
-1,77 մլն
Net profit margin
1 241,67%
-1 690,76%
-1 757,48%
-509,51%
Earnings per share
-0,46
-0,62
-0,61
-0,13
Interest and investment income
465,00 հզր
1,38 մլն
1,17 մլն
3,65 մլն
Interest expense
-453,00 հզր
-1,93 մլն
-3,88 մլն
-975,00 հզր
Net interest expenses
12,00 հզր
-545,00 հզր
-2,71 մլն
2,68 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,44 մլն
-4,70 մլն
-2,98 մլն
-1,97 մլն
Gain or loss from assets sale
12,00 հզր
-27,00 հզր
-23,00 հզր
9,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps